Interventional and device-based autonomic modulation in heart failure

Mark J. Shen, Douglas P. Zipes

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

"Heart failure is an increasingly prevalent disease with high mortality and public health burden. It is associated with autonomic imbalance characterized by sympathetic hyperactivity and parasympathetic hypoactivity. Evolving novel interventional and device-based therapies have sought to restore autonomic balance by neuromodulation. Results of preclinical animal studies and early clinical trials have demonstrated the safety and efficacy of these therapies in heart failure. This article discusses specific neuromodulatory treatment modalities individually-spinal cord stimulation, vagus nerve stimulation, baroreceptor activation therapy, and renal sympathetic nerve denervation".

Original languageEnglish
Pages (from-to)337-348
Number of pages12
JournalHeart Failure Clinics
Volume11
Issue number2
DOIs
StatePublished - Apr 1 2015

Fingerprint

Heart Failure
Equipment and Supplies
Vagus Nerve Stimulation
Spinal Cord Stimulation
Pressoreceptors
Sympathectomy
Therapeutics
Public Health
Clinical Trials
Kidney
Safety
Mortality

Keywords

  • Autonomic nervous system
  • Baroreflex activation therapy
  • Heart failure
  • Renal sympathetic nerve denervation
  • Spinal cord stimulation
  • Vagus nerve stimulation

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Interventional and device-based autonomic modulation in heart failure. / Shen, Mark J.; Zipes, Douglas P.

In: Heart Failure Clinics, Vol. 11, No. 2, 01.04.2015, p. 337-348.

Research output: Contribution to journalArticle

Shen, Mark J. ; Zipes, Douglas P. / Interventional and device-based autonomic modulation in heart failure. In: Heart Failure Clinics. 2015 ; Vol. 11, No. 2. pp. 337-348.
@article{688d02e969444cf78526eed7ab40052d,
title = "Interventional and device-based autonomic modulation in heart failure",
abstract = "{"}Heart failure is an increasingly prevalent disease with high mortality and public health burden. It is associated with autonomic imbalance characterized by sympathetic hyperactivity and parasympathetic hypoactivity. Evolving novel interventional and device-based therapies have sought to restore autonomic balance by neuromodulation. Results of preclinical animal studies and early clinical trials have demonstrated the safety and efficacy of these therapies in heart failure. This article discusses specific neuromodulatory treatment modalities individually-spinal cord stimulation, vagus nerve stimulation, baroreceptor activation therapy, and renal sympathetic nerve denervation{"}.",
keywords = "Autonomic nervous system, Baroreflex activation therapy, Heart failure, Renal sympathetic nerve denervation, Spinal cord stimulation, Vagus nerve stimulation",
author = "Shen, {Mark J.} and Zipes, {Douglas P.}",
year = "2015",
month = "4",
day = "1",
doi = "10.1016/j.hfc.2014.12.010",
language = "English",
volume = "11",
pages = "337--348",
journal = "Heart Failure Clinics",
issn = "1551-7136",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Interventional and device-based autonomic modulation in heart failure

AU - Shen, Mark J.

AU - Zipes, Douglas P.

PY - 2015/4/1

Y1 - 2015/4/1

N2 - "Heart failure is an increasingly prevalent disease with high mortality and public health burden. It is associated with autonomic imbalance characterized by sympathetic hyperactivity and parasympathetic hypoactivity. Evolving novel interventional and device-based therapies have sought to restore autonomic balance by neuromodulation. Results of preclinical animal studies and early clinical trials have demonstrated the safety and efficacy of these therapies in heart failure. This article discusses specific neuromodulatory treatment modalities individually-spinal cord stimulation, vagus nerve stimulation, baroreceptor activation therapy, and renal sympathetic nerve denervation".

AB - "Heart failure is an increasingly prevalent disease with high mortality and public health burden. It is associated with autonomic imbalance characterized by sympathetic hyperactivity and parasympathetic hypoactivity. Evolving novel interventional and device-based therapies have sought to restore autonomic balance by neuromodulation. Results of preclinical animal studies and early clinical trials have demonstrated the safety and efficacy of these therapies in heart failure. This article discusses specific neuromodulatory treatment modalities individually-spinal cord stimulation, vagus nerve stimulation, baroreceptor activation therapy, and renal sympathetic nerve denervation".

KW - Autonomic nervous system

KW - Baroreflex activation therapy

KW - Heart failure

KW - Renal sympathetic nerve denervation

KW - Spinal cord stimulation

KW - Vagus nerve stimulation

UR - http://www.scopus.com/inward/record.url?scp=84926117451&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84926117451&partnerID=8YFLogxK

U2 - 10.1016/j.hfc.2014.12.010

DO - 10.1016/j.hfc.2014.12.010

M3 - Article

C2 - 25834979

AN - SCOPUS:84926117451

VL - 11

SP - 337

EP - 348

JO - Heart Failure Clinics

JF - Heart Failure Clinics

SN - 1551-7136

IS - 2

ER -